Close Asset Management LTD Organon & Co. Transaction History

Close Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$17.45 - $21.96 $1,570 - $1,976	-90 Reduced 92.78%	7 $0
Q1 2024 May 14, 2024	BUY	$13.78 - $18.8 $1,336 - $1,823	97 New	97 $2,000
Q2 2022 Jul 29, 2022	SELL	$31.66 - $38.9 $3,197 - $3,928	-101 Reduced 50.25%	100 $3,000
Q4 2021 Jan 27, 2022	SELL	$28.67 - $37.13 $4,300 - $5,569	-150 Reduced 42.74%	201 $6,000
Q3 2021 Nov 04, 2021	SELL	$28.63 - $35.64 $3,120 - $3,884	-109 Reduced 23.7%	351 $12,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $13,087 - $17,480	460 New	460 $14,000

794

202M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.03B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Close Asset Management LTD with notifications on news.